Medical News

RSS

PlusNews examines cases of hospital-acquired HIV in Africa

PlusNews examines several recent reports that highlight how unsanitary hospital procedures can create an environment conducive to the spread of HIV/AIDS.

8 Dec 2009

Reuters news examines quest for new TB drugs, vaccines

Reuters examines the search for new tuberculosis medicines and vaccines. "Although TB has plagued humankind for thousands of years, there is only one vaccine," which isn't very effective and doesn't protect adults. "With the exception of rifabutin, there has been no new drug for TB for more than 40 years," the news service writes.

8 Dec 2009

Also in Global Health news: Rotavirus vaccine; guinea worm eradication; health systems; Zulu King calls for male circumcision

The West African Rotavirus Advisory Board is calling on governments to vaccinate children against rotavirus, IRIN reports. At a recent meeting in Dakar, Senegal, which was "financed by GlaxoSmithKline, makers of one of two rotavirus vaccines" the board issued a document recommending that governments "immediately recognize the magnitude of the rotavirus problem and make vaccination against the virus a priority" (12/8).

8 Dec 2009

FIFA uses soccer to teach African youth about HIV/AIDS, other issues

Ahead of next year's World Cup of soccer tournament, FIFA on Saturday in Khayelitsha, South Africa, opened the first of an anticipated 20 centers in Africa aimed at educating the youth about HIV/AIDS and other social issues through the sport, the Associated Press reports (Jacobson, 12/5).

8 Dec 2009

EPA declares greenhouse gases a threat to public health; other health issues addressed at climate conference

The Environmental Protection Agency (EPA) on Monday "said greenhouse gases are a danger to public health and welfare in a decision that could eventually lead to new emissions regulations," the Wall Street Journal reports (Ball/Forelle/Talley, 12/7). According to the Associated Press/ABC News, the declaration on the opening day of the U.N. Climate Change Conference "signaled the [Obama] administration was prepared to push ahead for significant controls in the U.S. if Congress doesn't act first on its own" (Herbert/Cappiello, 12/7).

8 Dec 2009

Swine flu news round-up

The German government is looking to sell over 2 million leftover doses of the H1N1 (swine flu) vaccine, the country's health minister said Monday, Agence France-Presse reports. "A health ministry senior official in the state of Thuringia, Hartmut Schubert, said that the vaccines could even be donated and that there had been requests from Afghanistan and Eastern European countries including Ukraine," the news service adds (12/7).

8 Dec 2009

Aid agencies launch $378M 2010 aid request to improve health in Zimbabwe

More than 70 agencies, led by the U.N., launched a request on Monday for $378 million in aid, which will be used to improve health and food security, as well as water and sanitation, Reuters reports. Though Zimbabwe's power-sharing government has improved some "social conditions in the country," the agencies "say more needs to be done" (Banya, 12/7).

8 Dec 2009

Updated clinical data of Calistoga Pharmaceuticals’ delta selective PI3K inhibitor presented

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company’s oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.

8 Dec 2009

CSL Behring selects BioRx as an approved Berinert provider

BioRx, a specialty pharmacy company, has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.

8 Dec 2009

RIVA System effective in automatically compounding IV doses in syringes with minimal contamination

A recent study demonstrated the RIVA System (Robotic Intravenous Automation) - a self-contained unit for aseptic compounding from Intelligent Hospital Systems (IH Systems) - is an effective tool in automatically compounding IV doses in syringes and bags with minimal drug contamination.

8 Dec 2009

Acesis Performance Improvement Platform provides digital performance assessment capabilities for hospitals

Acesis, the enterprise software firm, headquartered in Silicon Valley and focused on healthcare, today announced its expanded technology solution, the Acesis Performance Improvement Platform that provides hospitals digital performance assessment capabilities that can be easily set up for each hospital’s unique vision of quality care.

8 Dec 2009

Applied Spine Technologies: Two Stabilimax surgeries performed in South Africa

Applied Spine Technologies announced today the first two Stabilimax surgeries performed outside of the United States. The surgeries were performed in Johannesburg, South Africa, by Ajay Maharaj, MD, at Sunninghill Hospital. The Stabilimax Dynamic Spine System is currently part of an IDE multi-center, randomized, controlled clinical trial in the U.S.

8 Dec 2009

Micromet presents final data from its blinatumomab Phase 2 study for ALL

Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL).

8 Dec 2009

Lieberman draws increasing ire from Democrats, Reid criticized for GOP/slavery comments

News organizations are honing in on key players in the health reform debate.

8 Dec 2009

Personal stories highlight how reform will affect some individuals

News outlets are focusing on the stories of individual consumers to explain how health care reform legislation may affect the lives and health of people around the nation.

8 Dec 2009

Eli Lilly to pay Applied NeuroSolutions $250,000 for renewal of their collaboration

Applied NeuroSolutions, Inc., a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today announced that Eli Lilly and Company has agreed to a one-year renewal of its drug discovery collaboration. Lilly will pay $250,000 to Applied NeuroSolutions for the one-year collaboration renewal.

8 Dec 2009

Public option 'compromise' may rest on private insurers

The Associated Press/The Washington Post reports that "private insurers - not the government - would offer coverage under a compromise Democrats are considering ... the latest idea bears little resemblance to the original vision outlined by liberals, and embraced by Obama, during the 2008 presidential campaign. That called for the government to sell insurance to workers and their families in competition with industry giants like UnitedHealthcare" (Alonso-Zaldivar, 12/8).

8 Dec 2009

Utah project seeks to reduce 'overuse of health care'

News outlets report on a pilot project in Utah to reduce overuse of services and Medicaid cuts in Kansas.

8 Dec 2009

The National Fragile X Foundation awards $100,000 grant for study of minocycline in FXS children

The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS). Hagerman is an internationally recognized clinician and clinical researcher on FXS, the most common cause of inherited mental impairment.

8 Dec 2009

Senate vote on abortion amendment - a major hurdle to health bill - could occur today

The Washington Post reports that lawmakers in the Senate began consideration Monday "of an amendment to restrict abortion coverage" and a vote is expected today. The provision, "co-sponsored by Sens. Ben Nelson (D-Neb.) and Orrin G. Hatch (R-Utah), would bar individuals who receive federal insurance subsidies from purchasing private policies that cover elective abortions. It also would ban abortion coverage under a government plan" (Murray, 12/8).

8 Dec 2009

Medical News

PlusNews examines cases of hospital-acquired HIV in Africa

Reuters news examines quest for new TB drugs, vaccines

Also in Global Health news: Rotavirus vaccine; guinea worm eradication; health systems; Zulu King calls for male circumcision

FIFA uses soccer to teach African youth about HIV/AIDS, other issues

EPA declares greenhouse gases a threat to public health; other health issues addressed at climate conference

Swine flu news round-up

Aid agencies launch $378M 2010 aid request to improve health in Zimbabwe

Updated clinical data of Calistoga Pharmaceuticals’ delta selective PI3K inhibitor presented

CSL Behring selects BioRx as an approved Berinert provider

RIVA System effective in automatically compounding IV doses in syringes with minimal contamination

Acesis Performance Improvement Platform provides digital performance assessment capabilities for hospitals

Applied Spine Technologies: Two Stabilimax surgeries performed in South Africa

Micromet presents final data from its blinatumomab Phase 2 study for ALL

Lieberman draws increasing ire from Democrats, Reid criticized for GOP/slavery comments

Personal stories highlight how reform will affect some individuals

Eli Lilly to pay Applied NeuroSolutions $250,000 for renewal of their collaboration

Public option 'compromise' may rest on private insurers

Utah project seeks to reduce 'overuse of health care'

The National Fragile X Foundation awards $100,000 grant for study of minocycline in FXS children

Senate vote on abortion amendment - a major hurdle to health bill - could occur today

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News